From the Sector

NCTO President and CEO Kim Glas testifies on “COVID-19 Part II: Evaluating the Medical Supply Chain and Pandemic Response Gaps, before the Senate Homeland Security and Governmental Affairs Committee.

In written testimony submitted to the committee, Glas provides an overview of: the U.S. market prior to the pandemic and the root causes of America’s dependence on offshore sources for medical PPE; the heroic response of the U.S. textile industry; the federal government’s response to the crisis; and a series of policy recommendations to incentivize the establishment of a permanent domestic PPE supply chain.

Glas details key policy recommendations designed to establish a permanent domestic PPE supply chain, including:

• Create strong domestic procurement rules for federal PPE purchases and other essential products--substantially similar to the Berry Amendment and the Kissell Amendment which require 100% US content from fiber production forward
• Implement forward-looking policies to shore up the Strategic National Stockpile and issue long-term contracts to incentivize investment in the domestic PPE manufacturing base
• Create federal incentives for private sector hospitals and large provider networks to purchase domestically-produced PPE
• Continue to deploy the Defense Production Act to shore up the textile industrial base from raw materials to end products for all essential products

View the full written testimony here.